Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies Post author: Post published:November 1, 2023 Post category:uncategorized Researchers described an approach to edit the recombination-activating gene 2 (RAG2) locus for therapeutic applications. You Might Also Like New study sheds light on interferon combinations’ role in lupus variability May 14, 2024 Bird flu is bad for poultry and dairy cows. It’s not a dire threat for most of us — yet. May 3, 2024 hnRNPM’s protective role in protein synthesis precision uncovered May 30, 2024